Tirzepatide Rx Only

Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support advanced metabolic and weight management goals. Unlike traditional GLP-1 therapies alone, tirzepatide targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways to provide broader metabolic support


Potential Benefits

Potential benefits associated with Tirzepatide therapy may include:

  • Significant appetite reduction

  • Weight management support

  • Improved insulin sensitivity

  • Reduced food cravings

  • Metabolic optimization

  • Cardiometabolic wellness support

  • Body composition improvement


  • Monthly, 3-mo, and 6-mo plans

  • Starting price applies to 3-mo plan

  • US-licensed pharmacies

  • Pause or cancel anytime

Starting at $299

Free, discreet shipping

Ongoing Support

Subscribe & Save

Prescription medications require an online evaluation by a licensed medical professional. Compounded products are prepared by licensed U.S. pharmacies and are not reviewed or approved by the FDA. Packaging may differ from images shown.

$299/month

Applies to 1st month of 3 month plan

What’s included

  • Personalized, clinician-guided plan

  • Monthly, 3-month, and 6-month plans

  • Dispensed by US-licensed compounding pharmacy

  • Unlimited protocol adjustments and messaging

  • Ongoing support and check-ins

  • Pause or cancel anytime

What is Tirzepatide?

(tir-ZEP-uh-tide)

Tirzepatide is a synthetic 39-amino acid peptide that simultaneously activates both GIP and GLP-1 receptors, the two key incretin hormones regulating postprandial insulin secretion, appetite, and energy balance. This dual mechanism distinguishes it from earlier GLP-1 receptor agonists such as semaglutide and liraglutide, which target only the GLP-1 receptor.